Pre-Open Stock Movers 05/03: (MDP) (OCGN) (VIRX) Higher; (VXRT) (PETS) (EL) Lower (more...)

May 3, 2021 9:30 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Today's Pre-Open Stock Movers

Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) 33% HIGHER; adds to recent momentum gains.

Meredith Corporation (NYSE: MDP) 12.5% HIGHER; today announced that it has agreed to sell its Local Media Group ("LMG") to Gray Television, Inc. (NYSE: GTN) for $2.7 billion in cash and will focus exclusively on its National Media Group ("NMG") portfolio post-close. Under the terms of the transaction, Meredith's National Media Group will be spun out to shareholders as a standalone publicly traded company retaining the Meredith Corporation name, with shareholders receiving cash consideration per share of approximately $14.50 and 1-for-1 equity share in post-close Meredith. The transaction was unanimously approved by Meredith's and Gray's Board of Directors.

Ocugen, Inc. (NASDAQ: OCGN) 12.3% HIGHER; announced that in a new study, scientists at Indian Council of Medical Research (ICMR)-National Institute of Virology have found that COVAXIN demonstrated potential effectiveness against the Brazil variant of SARS-CoV-2, B.1.128.2. As previously disclosed, a study conducted by ICMR also suggested that COVAXIN was effective against the UK variant, B.1.1.7, as well as the Indian double mutant variant, B.1.617. It is notable that the Brazilian variant, B1.128.2, contains the E484K mutation that was found in New York.

Vaxart, Inc. (NASDAQ: VXRT) 9% LOWER; recent momentum stock reports earnings, provides update

Viracta Therapeutics (NASDAQ: VIRX) 7.2% HIGHER; H.C. Wainwright initiates coverage with a Buy rating and $35 price target.

BioNTech SE (NASDAQ: BNTX) 6.6% HIGHER; vaccine stocks gain.

PetMed Express (NASDAQ: PETS) 4.5% LOWER; reported Q4 EPS of $0.34, $0.06 worse than the analyst estimate of $0.40. Revenue for the quarter came in at $71.68 million versus the consensus estimate of $74.03 million.

Estee Lauder (NYSE: EL) 3.8% LOWER; reported Q3 EPS of $1.62, $0.33 better than the analyst estimate of $1.29. Revenue for the quarter came in at $3.86 billion versus the consensus estimate of $3.92 billion. Estee Lauder sees FY2021 EPS of $6.05-$6.15, versus the consensus of $6.00.

Clorox (NYSE: CLX) 1.8% LOWER; Wells Fargo downgraded from Overweight to Underweight, PT $170 (from $240.00).

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Special Reports

Related Entities

Earnings, Wells Fargo, Pre-Open Losers, Pre-Open Winners, Pre Market Movers, H.C. Wainwright